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The role of microRNA‑3085 
in chondrocyte function
Linh Le1,3,4, Lingzi Niu1,4, Matthew J. Barter2, David A. Young2, Tamas Dalmay1, 
Ian M. Clark1,5* & Tracey E. Swingler1,5
MicroRNAs have been shown to play a role in cartilage development, homeostasis and breakdown 
during osteoarthritis. We previously identified miR‑3085 in humans as a chondrocyte‑selective 
microRNA, however it could not be detected by Northern blot. The aim of the current study was to 
prove that miR‑3085 is a microRNA and to investigate the function of miR‑3085 in signaling pathways 
relevant to cartilage homeostasis and osteoarthritis. Here, we confirm that miR‑3085 is a microRNA 
and not another class of small RNA using (1) a pre‑miR hairpin maturation assay, (2) expression 
levels in a Dicer null cell line, and (3) Ago2 pulldown. MicroRNA‑3085‑3p is expressed more highly in 
micromass than monolayer cultured chondrocytes. Transfection of miR‑3085‑3p into chondrocytes 
decreases expression of COL2A1 and ACAN, both of which are validated as direct targets of miR‑
3085‑3p. Interleukin‑1 induces the expression of miR‑3085‑3p, at least in part via NFκB. In a feed‑
forward mechanism, miR‑3085‑3p then potentiates NFκB signaling. However, at early time points 
after transfection, its action appears to be inhibitory. MyD88 has been shown to be a direct target 
of miR‑3085‑3p and may be responsible for the early inhibition of NFκB signaling. However, at later 
time points, MyD88 knockdown remains inhibitory and so other functions of miR‑3085‑3p are clearly 
dominant. TGFβ1 also induces the expression of miR‑3085‑3p, but in this instance, it exerts a feedback 
inhibition on signaling with SMAD3 and SMAD4 shown to be direct targets. This in vitro analysis shows 
that miR‑3085‑3p functions in chondrocytes to induce IL‑1‑signaling, reduce TGFβ1 signaling, and 
inhibit expression of matrix genes. These data suggest that miR‑3085‑3p has a role in chondrocyte 
function and could contribute to the process of osteoarthritis.
Osteoarthritis (OA) is a degenerative disease of the articular joint, involving degradation of the articular car-
tilage, subchondral bone sclerosis and the formation of  osteophytes1,2. Several factors (genetic, developmental, 
biochemical and biomechanical) impact upon the etiology of  OA1. Cartilage homeostasis is dependent on the 
expression of appropriate genes by resident chondrocytes and this is aberrant in  OA3.
One class of small non-coding RNAs known as microRNAs (miRNAs) have a key role in the regulation of 
gene expression in human cells. MiRNAs are transcribed as primary transcripts (pri-miRNA) and processed to 
short stem-loop structures (pre-miRNA) in the nucleus. The pre-miRNA is then processed by the ribonuclease, 
Dicer, forming two complementary short RNA strands. One of these, the guide strand, is integrated into the 
RNA-induced silencing complex (RISC), the other, the passenger strand, is  degraded4. After integration into 
RISC, miRNAs base pair with their complementary mRNA targets, usually in the 3′UTR 5 to degrade mRNA or 
repress translation.
The miRNA pathway has a major role in skeletal development. The conditional knockout of Dicer in limb 
mesenchyme early in embryonic development leads to the formation of a smaller  limb6. Dicer-null growth plates 
show diminished chondrocyte proliferation, with enhanced differentiation to postmitotic hypertrophic chondro-
cytes. Conditional knockout of Dicer in chondrocytes results in defects in skeletal growth and premature  death7.
Many miRNAs are regulated during cartilage development, with a number of miRNAs regulated by the key 
cartilage-specifying transcription factor Sox9 (e.g. miR-140 and miR-455), or regulating Sox9 expression (e.g. 
miR-675 and miR-145  (see8).
MicroRNAs are dysregulated in OA and have a functional effect on disease progression in models of  disease8,9. 
Studies comparing expression of miRNAs in normal vs osteoarthritic human cartilage show little congruity, likely 
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because of varying sample groups and this makes interpretation difficult. However, understanding the roles of 
miRNAs in OA is important and may lead to novel  therapy8.
MicroRNA-140 is the most studied miRNA to date in cartilage and osteoarthritis. Universal knockout of 
miR-140 leads to mild dwarfism, probably as a result of impaired chondrocyte  proliferation10,11. Such dele-
tion of miR-140 in mice predisposed them to the development of age-related OA-like changes and increased 
cartilage destruction in surgically-induced OA, possibly through direct targeting of  Adamts510,11. A number of 
other targets have been identified and validated in vitro which have the potential to be involved in chondrocyte 
development and/or cartilage  homeostasis12.
We recently identified a miRNA in humans, previously sequenced (but uncharacterised) in mice and rats, 
microRNA-3085. We went on to demonstrate that miR-3085 was expressed selectively in cartilage compared to 
other tissues and its expression rapidly decreased upon chondrocyte isolation and passage in monolayer  culture13. 
MicroRNA-3085 is genomically located within an intron of cartilage acidic protein 1 (CRTAC1, previously 
called CEP-68), the function of which is  unknown14. CRTAC1 is expressed in both cartilage and bone tissue, 
but rapidly lost from osteoblasts on  culture14 and like miR-3085, its expression is also markedly decreased when 
chondrocytes are digested from  cartilage15. CRTAC1 is also reported to be increased in expression in arrays of 
human OA cartilage (e.g.16).
The purpose of the current study was to: (1) prove that miR-3085 was a microRNA and not another type 
of small RNA; (2) investigate the function of miR-3085 in signaling pathways relevant to cartilage homeostasis 
and osteoarthritis.
Materials and methods
Cell culture. SW1353 chondrosarcoma cells were from the American Type Culture Collection, parental and 
DLD-1 Dicer null cell lines were from Horizon Discovery and originated from a colorectal adenocarcinoma. 
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Thermo Fisher Scientific) with GlutaMAX 
containing 10% (v/v) fetal bovine serum (Sigma Aldrich), 100 IU/ml penicillin and 100 μg/ml streptomycin, 
37 °C, 5% (v/v)  CO2 under normoxia, as  described17.
Primary human articular chondrocytes (HACs) were isolated from cartilage of osteoarthritis patients as 
 described18 and cultured as above. All experimental protocols were approved by NRES Committee East of Eng-
land (ref: 08/h0304/85 + 5). All tissue donors gave informed written consent. All methods were performed in 
accordance with relevant laboratory guidelines and institutional regulations for research using human tissues 
and body fluids.
For micromass  culture19, primary HACs were grown in monolayer culture in DMEM high glucose, with 
GlutaMAX (Thermo Fisher Scientific), containing 10% (v/v) fetal bovine serum (Sigma Aldrich), 100 IU/ml 
penicillin and 100 μg/ml streptomycin (Thermo Fisher Scientific) (growth medium) at 37 °C, 5% (v/v)  CO2 until 
passage two. Confluent cells were then trypsinised and resuspended at a density of 2 × 107 in growth medium. 
Micromass was obtained by pipetting 20 μl cell suspension into individual wells of 24-well plates and incubating 
for 3 h to attach. One ml growth medium was then added, and the micromass was incubated for 24 h. Growth 
medium was then replaced with DMEM high glucose, with GlutaMax (Thermo Fisher Scientific) containing 
1 × insulin-transferrin-selenium (Thermo Fisher Scientific) and 0.5% (v/v) fetal bovine serum (Sigma Aldrich), 
with or without recombinant human TGFβ1 (4 ng/ml) (R&D Systems) or IL-1β (5 ng/ml) (First Link (UK) Ltd) 
for 24 h. Inhibition of NFκB was achieved using JSH-23 at 10 μM (Calbiochem). JSH-23 was added 1 h before 
adding IL-1β and was kept in culture media for another 24 h.
Transient transfection. The 3′UTR of mRNAs containing the predicted binding site of miR-3085-3p were 
subcloned into pmirGLO (Promega), using QuikChange II XL site-directed mutagenesis kit (Agilent) to intro-
duce mutations. Constructs were sequence verified (Source Bioscience). SW1353 cells were seeded into 96-well 
plate wells at 5 × 104 cells/ml in 100 ul medium overnight and transiently transfected with 100 ng reporter plas-
mid, 50 nM miR-3085-3p mimic (Qiagen) or non-targeting control (Negative Control miRCURY LNA miRNA 
Mimic, Qiagen) using Lipofectamine 3000 (Thermo Fisher Scientific), according to manufacturer’s instructions 
for either 24 h or 48 h  (see20). Cell lysates were assayed for luciferase using the Dual Luciferase Reporter Assay 
Kit (Promega), read with an EnVision 2103 Multilabel plate reader (Perkin Elmer). Relative luciferase activity 
was the ratio of firefly luciferase to Renilla luciferase  activity20.
Signalling pathways were measured using p(CAGA)12-luc (Smad2/3)21; κB-luc (NFκB)22; TOPFlash (canoni-
cal Wnt)  reporters23. 100 ng of the plasmid and 10 ng of constitutive Renilla plasmid were co-transfected into 
SW1353 cells with 50 nM miR-3085-3p mimic or non-targeting control. After serum starvation for 24 h, cells 
were treated with either TGFβ1 (4 ng/ml) (R&D Systems) or IL-1β (5 ng/ml) (First Link (UK) Ltd) for 6 h. 
Luciferase activity and data analysis were as described above.
HACs were plated in 96-well plate wells at a density of 7 × 104 cells/ml in 100 µl, and grown to 80%-90% 
confluence. MicroRNA-3085-3p mimic (50 nM), non-targeting control (50 nM), MyD88 siRNA (50 nM) and 
negative control siRNA (50 nM) (AllStars Negative Control siRNA, Qiagen) were transfected as described above 
 and20. Cells were then incubated at 37 °C in 5%  CO2 for 48 h. After serum starvation for 24 h, cells were treated 
with recombinant human TGFβ1 (4 ng/ml) (R&D Systems), IL-1β (5 ng/ml) (First Link (UK) Ltd) for another 
8 h20, followed by RNA isolation.
RNA isolation and qRT‑PCR. Trizol reagent (Thermo Fisher Scientific) was used to isolate total RNA 
from cultured cells according to manufacturer’s instructions. The miRCURY LNA Universal cDNA synthesis kit 
(Exiqon) and miRNA-specific LNA primers (Exiqon) was used for quantification of mature miRNA transcripts 
by qRT-PCR. Data were normalized to U6 as the housekeeping gene. For mRNA, Ambion Cells-to-cDNA II Kit 
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(Life Technologies) or SuperScript II RT (Thermo Fisher Scientific) was used with data normalised to expression 
of 18S rRNA ribosomal RNA. Only samples where the housekeeping genes are expressed within median + /− 1 
Ct are included in analyses. Primer sequences are listed in Supplementary Table 1. Both miRNA and mRNA 
relative quantifications were calculated using the ∆∆CT method. Fluorescence for each cycle was analysed by the 
real-time PCR 7500 system (Applied Biosystems)20.
Western blot. SW1353 cells were plated in 6-well plate wells at 1.5 × 105 cells/well and left to adhere over-
night. Cells were transiently transfected with 50 nM miR-3085-3p mimic (Qiagen), siRNA (Qiagen) or non-
targeting controls (Qiagen) for 48 h. After serum starvation for another 24 h, cells were stimulated with IL-1β 
(5 ng/ml) (First Link (UK) Ltd) for 30 min or TGFβ1 (4 ng/ml) (R&D Systems) for 2 h and washed twice in 
ice-cold phosphate buffered saline (PBS). Whole cell lysates were harvested into ice cold RIPA buffer (50 mM 
Tris–HCL pH7.6, 150 mM NaCl, 1% (v/v) Triton x-100, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 10 mM 
NaF, 2 mM  Na3VO4, 1 × protease inhibitor cocktail III (Thermo Fisher Scientific)). Samples were separated on 
reducing SDS-PAGE, transferred to PVDF membrane and probed overnight at 4 °C. The p65 (#8242), phospho-
p65 (#3033), IκBα (#4814), phosphor-IκBα (#2859),SMADs (#3103, #9513, #38,454), phospho-SMADs (#9523), 
MyD88 (#4283), β-catenin (#9582), phospho-β-catenin (#9561) and GAPDH (#2118) (all from Cell Signaling 
Technology, used at recommended concentrations) were detected using HRP-conjugated secondary antibodies 
(DAKO), visualised using Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific), and imaged by 
ChemiDoc MP Imaging System (Biorad)13.
Cellular fractionation. SW1353 cells were plated in 60-mm culture dishes at 3.5 × 105 cells/dish overnight. 
The cells were then transiently transfected with either miR-3085-3p mimic (Qiagen) or non-targeting control 
(Qiagen), serum starved, and treated with IL-1β or TGFβ1 as described above. Nuclear and cytosolic fractions 
were purified using the Nuclear and Cytoplasmic Extraction kit (Thermo Fisher Scientific) according to manu-
facturer’s instructions, using 1 × protease inhibitor cocktail III (Thermo Fisher Scientific), 1 × phosphatase inhib-
itor cocktail 2 (Sigma Aldrich), and 1 × phosphatase inhibitor cocktail 3 (Sigma Aldrich).
Hairpin maturation assay. An approximately 500 bp region containing the precursor of miR-140 or miR-
3085 sequences was sub-cloned into pcDNA3.0. Primers for sub-cloning miR-3085 were.
5′-ATG CAA GCT TAG GAT CAA GAG CAG GAT TGG -3′,
5′-ATG CAA GCT TCT GGC CTC AGA GAA GAC TGG -3′ and for miR-140 were
5′-ATG CAA GCT TAG AGA GAG AGA GCG CTG TGG -3′,
5′-ATG CAA GCT TGC AAC ACT CTT GCA CTT TGC -3′.
SW1353 cells were transiently transfected using Lipofectamine 3000 (Thermo Fisher Scientific) according 
to manufacturer’s instructions) with expression constructs for either precursor miR-140 or precursor miR-3085 
compared to an empty vector and cultured for 48 h. RNA was isolated and miRCURY LNA Universal cDNA 
synthesis kit (Exiqon) and miRNA-specific LNA primers (Exiqon) for U6, miR-3085-3p and miR-140-5p were 
used for quantification of mature miRNA transcripts by qRT-PCR.
Agonaute pulldown. SW1353 cells were transiently transfected with either precursor miR-140 or precur-
sor miR-3085 for 48 h as above. Cell lysates were harvested with 0.5%(v/v) NP40, 150 mM KCl, 25 mM Tris–gly-
cine pH7.5, 2 mM EDTA, 0.5 mM DTT, and 1 × protease inhibitor cocktail III (Thermo Fisher Scientific). Sam-
ples were pulled down with Ago2 antibody (MABE253, Sigma Aldrich) using Dynabeads Protein G (Thermo 
Fisher Scientific) and DynaMag Magnet at 4 °C, overnight. In order to quantify miRNA expression, targeted 
Ago2 was eluted with Cells-to-cDNA II lysis buffer (Thermo Fisher Scientific) and the miRCURY LNA Universal 
cDNA synthesis kit (Exiqon, Denmark) and miRNA-specific LNA primers (Exiqon, Denmark) for miR-140-3p, 
miR-29b-3p, and miR-3085-3p were used for quantification of mature miRNA transcripts by qRT-PCR.
Statistical analysis. Data were tested for normal distribution and analysed using Student’s t-test to com-
pare between two samples, or one-way ANOVA with post-hoc Tukey’s test to compare between multiple samples 
using GraphPad Prism version 6. Experiments were performed on three independent replicates (n = 3); for pri-
mary human chondrocytes, three different patient isolates were used.
Results
MicroRNA‑3085 is a microRNA. Northern blot of chondrocyte RNA probed for miR-3085 failed to show 
a  signal13. In order to verify the identity of this RNA as a microRNA, an expression construct of the presumed 
pre-miR-3085 hairpin sequence was transiently transfected into SW1353 cells. This lead to a statistically signifi-
cant increase in the mature miR-3085-3p (p < 0.001, Fig. 1A). As a positive control, the same increase in mature 
miR-140-3p was measured after transfection with pre-miR-140 expression construct (Fig. 1B). Furthermore, 
this increase in mature miR-3085-3p was significantly reduced in DLD-1 Dicer null cells compared to isogenic 
wild-type cells (p < 0.001, Fig. 1C). Finally, mature miR-3085-3p was immunoprecipitated with an anti-AGO2 
antibody after transfection with pre-miR-3085 (but not pre-miR-140) and vice versa (Fig. 1D,E). Western blot of 
the immunoprecipitates with anti-AGO2 shows equal loading (Supplementary Fig. 1).
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MicroRNA‑3085‑3p modulates the expression of matrix genes. The expression of miR-3085-3p is 
increased by micromass (three-dimensional) culture of human articular chondrocytes (p < 0.05, Fig. 2A), which 
significantly enhances expression of matrix  genes19. However, the overexpression of miR-3085 represses the 
expression of both COL2A1 (p < 0.001) and ACAN (p < 0.01), though SOX9 expression shows a small increase 
(p < 0.05) (Fig. 2B). Expression of luciferase controlled by the 3′UTR of either the COL2A1 or ACAN gene shows 
that miR-3085-3p significantly reduces this expression and that this is rescued by mutation of the miR-3085-3p 
seed site in each UTR (Fig. 2C,D). This shows that these genes are direct targets of miR-3085-3p.
MicroRNA‑3085‑3p and NFκB signaling. Interleukin-1 and NFκB signaling are deemed key in  OA1,24. 
Interleukin-1β induces expression of miR-3085-3p in primary human articular chondrocytes in either mon-
olayer or micromass culture (p < 0.001, Fig.  3A, micromass) and this is in part dependent on NFκB signal-
ing (Fig. 3B). IL-1-induced activation of an NFκB reporter, transiently transfected into SW1353 cells is further 
increased by co-transfection with miR-3085-3p (p < 0.01, Fig. 3C), with the same pattern seen for IL-1 induced 
Figure 1.  miR-3085 is a microRNA. (A) SW1353 chondrosarcoma cells were transiently transfected with 
expression plasmids for either (A). pre-miR-3085 hairpin or (B). pre-miR-140 hairpin and empty vector 
(pcDNA3) control and cultured for 48 h. Expression of mature miR-3085-3p or miR-140-3p was measured 
by qRT-PCR. (C) Parental DLD-1 cells or isogenic Dicer null (KO) cells were transiently transfected with 
expression plasmids for pre-miR-3085 hairpin and culture for 48 h. Expression of mature miR-3085-3p 
was measured by qRT-PCR. (D,E). SW1353 cells were transiently transfected with either pre-miR-3085 or 
pre-miR-140 for 48 h, cell lysates were immunoprecipitated using an Ago2 antibody; mature miR-3085-3p, 
miR-140-3p and miR-29b-3p were measured by qRT-PCR. Mean + /− SEM, n = 3; (A,B) Student’s t-test; (C–E), 
ANOVA with Tukey’s post test; **p < 0.01; ***p < 0.001.
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MMP13 expression in HACs (p < 0.05, Fig. 3D), at 8 or 6 h of induction respectively. However, at an optimal 
early time point (30 min), miR-3085-3p mimic decreased nuclear levels of IL-1-induced p65 and phospho-p65 
(Fig. 3E). Indeed, time course data from qRT-PCR of IL-1 induced MMP13 expression did not show a response 
until 6 h of stimulation (Supplementary Fig. 2).
Since MyD88 is an adapter protein involved in IL-1  signalling25 and MyD88 is predicted to be a direct target 
of miR-3085-3p, we explored this further. MyD88 is experimentally shown to be a direct target of miR-3085-3p, 
though rescue by mutation of the seed site is partial rather than complete (Fig. 4A). Quantitative RT-PCR 
(Fig. 4B) and western blot (Fig. 4C) also demonstrates that overexpression of miR-3085-3p leads to a decrease in 
MyD88 mRNA (p < 0.001) and protein. Treatment with siRNA against MyD88 leads to a decrease in phospho-p65 
(Fig. 4D) and it also decreases IL-1-induced MMP13 expression (p < 0.05, Fig. 4E), so this is not the mechanism 
by which miR-3085-3p potentiates IL-1/ NFκB signaling.
MicroRNA‑3085‑3p and Smad signaling. TGFβ-signalling is also key in  OA1,24. Similar to IL-1, TGFβ1 
also induces expression of miR-3085-3p (p < 0.05, Fig.  5A). In this instance, miR-3085-3p does not show a 
significant effect on TGFβ1-induced luciferase from a Smad-responsive luciferase reporter (CAGA 12) (Sup-
plementary Fig. 3). TGFβ1-induced expression of the inhibitor of DNA-binding 1 (ID1) gene is repressed by 
over-expression of miR-3085-3p (p < 0.01, Fig. 5B). SMAD3 and SMAD4 are direct targets for miR-3085-3p; a 
SMAD2 3′ UTR construct is also repressed by miR-3085-3p, but this repression is not rescued by mutation of the 
seed site (Fig. 5C–E). In total cell extracts, miR-3085-3p reduced expression of SMAD2, SMAD3 and SMAD4 
protein (Fig. 5F), whilst in fractionated cells these SMADs were decreased in the nuclear fraction (Fig. 5G) and 
phospho-SMAD3 was also reduced in whole cell extracts (Fig. 5H).
Figure 2.  miR-3085 downregulates type II collagen and aggrecan expression. (A) Primary human articular 
chondrocytes were cultured in micromass culture for 48 h; miR-3085-3p was measured by qRT-PCR. (B) 
Micromass cultures of primary human articular chondrocytes transfected with miR-3085-3p mimic or 
non-targeting control (NTC) for 48 h; COL2A1 and ACAN were measured by qRT-PCR. SW1353 cells were 
transiently transfected with the (C). ACAN 3′UTR and (D). COL2A1 3′UTR subcloned into the pmirGLO 
vector (wild-type) or a construct with miR-3085-3p seed sites mutated (mutant) with miR-3085-3p mimic 
or non-targeting control (NTC) for 24 h. Firefly luciferase relative light units were normalised to Renilla 
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Discussion
MicroRNA-3085 was identified in humans during a small RNA-Seq experiment in primary human articular 
chondrocytes from osteoarthritis  patients13 where it was shown to be genomically located in the final intron for 
CRTAC1, a gene expressed in cartilage. It had previously been identified in mouse and rat genomes, but was 
intergenic in these, though new annotation now shows it also overlaps with CRTAC1 in the rat genome (Ensembl 
Release 92, data not shown).
In northern blot experiments in RNA purified from cells, expression was  undetectable13. It has previously 
been noted that poorly expressed microRNAs require validation via more sensitive  methodologies26. We therefore 
looked at its identity as a miRNA using three experiments: transient transfection of an expression plasmid for 
the hairpin precursor sequence and measuring the mature miR-3085-3p27,28; an identical experiment comparing 
Figure 3.  IL-1 induces miR-3085-3p which represses NFκB signaling. Primary human articular chondrocytes 
were cultured in micromass culture for 48 h. (A) cells were then treated with IL-1β (5 ng/ml) or control for 24 h; 
(B) cells were then treated with IL-1β (5 ng/ml) or control + /− an NFκB inhibitor JSH-23 (10 μM) or vehicle 
24 h; miR-3085-3p was measured by qRT-PCR. (C) SW1353 cells were transfected with an NFκB luciferase 
reporter + /− miR-3085-3p mimic or non-targeting control (NTC) for 24 h prior to stimulation with IL-1β 
(5 ng/ml) or control for 8 h. (D) Primary human articular chondrocytes were grown in monolayer culture 
and transiently transfected with miR-3085-3p or a non-targeting control (NTC) for 24 h prior to stimulation 
with IL-1β (5 ng/ml) or control for 6 h; MMP13 was measured by qRT-PCR. Mean + /− SEM, n = 3; Student’s 
t-test; *p < 0.05; **p < 0.01; ***p < 0.001. (E) SW1353 cells were grown in monolayer culture and transiently 
transfected with miR-3085-3p or a non-targeting control for 48 h, serum starved for 24 h and stimulated with 
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isogenic cell lines which are wild-type or Dicer  null29; pull down with anti-Argonaute  antibody30. In each case, 
miR-3085 behaved in an identical manner to a miR-140 control, providing strong evidence that it is a miRNA 
rather than any other species of small RNA.
Expression of miR-3085-3p increases when cells are grown in micromass culture compared to monolayer. 
This is a similar pattern to CRTAC-1  itself31, suggesting that they may be regulated by the same promoter. How-
ever, overexpression of Sox9, the master regulator of the chondroctye phenotype, significantly induces CRTAC1 
expression but has a lesser effect on miR-3085-3p expression (data not shown). MicroRNA-3085-3p increases 
expression of SOX9 in primary HACs in micromass culture, but decreases expression of both COL2A1 and ACAN 
Figure 4.  MyD88 is a direct target of miR-3085-3p. (A) SW1353 cells were transiently transfected with the 
MyD88 3′UTR subcloned into the pmirGLO vector (wild-type) or a construct with miR-3085-3p seed sites 
mutated (mutant) with miR-3085-3p mimic or non-targeting control (NTC) for 24 h. Firefly luciferase relative 
light units were normalised to Renilla relative light units to give overall relative light units. (B) Primary human 
articular chondrocytes were grown in monolayer culture and transiently transfected with miR-3085-3p or 
a non-targeting control (NTC) for 48 h; MyD88 was measured by (B) qRT-PCR and (C) SW1353 cells were 
transfected with miR-3085-3p or a non-targeting control (NTC) for 48 h, MyD88 protein level were measured 
by western blot. (D) Primary human articular chondrocytes were grown in monolayer culture and transiently 
transfected with MyD88 siRNA or a non-targeting control (NTC) for 24 h prior to stimulation with IL-1β (5 ng/
ml) or control for 6 h; MMP13 was measured by qRT-PCR. Mean + /- SEM, n = 3. Student’s t-test; *p < 0.05; 
**p < 0.01; ***p < 0.001. (E) SW1353 cells were grown in monolayer culture and transiently transfected with 
MyD88 siRNA or a non-targeting control (NTC) for 24 h prior to stimulation with IL-1β (5 ng/ml) or control 
for 30 min prior to western blot analysis. Full-length blots are presented in Supplementary data; N.B. the full 
blot for MyD88 in (C) is over saturated.
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Figure 5.  TGFβ induces miR-3085-3p which represses Smad signaling. Primary human articular chondrocytes 
were cultured in micromass culture for 48 h. (A) cells were then treated with TGFβ1 (4 ng/ml), or control for 
24 h; miR-3085-3p was measured by qRT-PCR. (B) Primary human articular chondrocytes were grown in 
monolayer culture and transiently transfected with miR-3085-3p or a non-targeting control (NTC) for 24 h 
prior to stimulation with TGFβ1 (4 ng/ml), or control for 6 h; ID1 was measured by qRT-PCR. (C–E) SW1353 
cells were transiently transfected with the (C) Smad2, (D) Smad3, (E) Smad4. 3′UTR subcloned into the 
pmirGLO vector (wild-type) or a construct with miR-3085-3p seed sites mutated (mutant) with miR-3085-3p 
mimic or non-targeting control (NTC) for 24 h. Firefly luciferase relative light units were normalised to Renilla 
relative light units to give overall relative light units. Mean + /− SEM, n = 3; Student’s t-test; *p < 0.05; **p < 0.01; 
***p < 0.001. (F) SW1353 cells were transiently transfected with miR-3085-3p or a non-targeting control for 48 h 
prior to western blot analysis. (G) SW1353 cells were grown in monolayer culture and transiently transfected 
with miR-3085-3p or a non-targeting control for 48 h prior to stimulation with TGFβ1 (4 ng/ml), or control for 
2 h, fractionation and western blot analysis. (H) SW1353 cells were grown in monolayer culture and transiently 
transfected with miR-3085-3p or a non-targeting control for 48 h prior to stimulation with TGFβ1 (4 ng/ml), or 
control for 2 h and western blot analysis. Full-length blots are presented in Supplementary data.
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genes. These genes are direct targets of miR-3085-3p and this direct effect appears to be dominant in regulating 
COL2A1 and ACAN expression.
Interleukin-1 induces expression of miR-3085-3p and this is in part mediated by NFκB signaling. Interleu-
kin-1 induction of an NFκB -induced luciferase reporter is further induced by overexpression of miR-3085-3p 
and this is reinforced by a similar effect on the IL-1-induced expression of the MMP13 gene. Whilst we have 
identified MyD88 as a direct target of miR-3085-3p, we have excluded its role in the effect of the microRNA 
on IL-1 signaling. The direct target of miR-3085-3p responsible has not been identified either using prediction 
software or by experimental overexpression of miR-3085-3p followed by  microarray13.
Transforming growth factor beta also induces expression of miR-3085-3p, however the miRNA has no sig-
nificant effect on the (CAGA) 12 Smad sensitive reporter. This is difficult to explain, since miR-3085-3p clearly 
decreases expression of Smads 2–4 at both mRNA and protein level. However, the TGFβ1 -induced expression 
of ID1, used as a model TGFβ1-inducible gene, was repressed by the overexpression of miR-3085-3p. Interest-
ingly, two other genes often used to demonstrate induction by TGFβ1, PAI1 and TIMP3, are both predicted to 
be direct targets of miR-3085-3p and therefore not useful in this context.
The effect of miR-3085-3p on IL-1 signalling represents a feed-forward mechanism, whilst on TGFβ-
signalling, it is feed-back. Both of these have been described for microRNAs  previously32.
Some of the experiments reported have been performed in the SW1353 chondrosarcoma cell line and not 
in primary HACs. Whilst this is a limitation, the addition of exogenous miR-3085-3p to cell lines does demon-
strate the impact of the miRNA on signaling pathways and their outcome. For experiments requiring transient 
transfection of plasmid DNA, we find that its efficiency in HACs is low and this restricts its utility to cell lines.
These data strongly suggest that miR-3085 functions in cartilage signaling and homeostasis. We have shown 
that it decreases matrix gene expression, enhances IL-1 signalling and decreases TGFβ signaling, suggesting 
that it acts to promote catabolism. However, since miRNAs regulate the expression of a number of genes and 
pathways, this would be best investigated in vivo. Whilst we were able to gain founder mice with deletions of 
miR-3085 using CrispR-Cas9, we could not breed these forwards to germline. We are not certain if this is simply 
a technical issue or whether the miRNA has a more critical function in development.
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